MSH2 and Lynch syndrome: In this study, the sebaceous lesions from those individuals with a MSH2 germline mutation and an identified second somatic hit of the wild‐type allele (Lynch syndrome) demonstrated a significantly higher tumor mutational burden and number of somatic indels at exonic microsatellites, compared with the MMR‐proficient non‐Lynch sebaceous lesions.